BCA
CMD

Berman Capital Advisors’s Cantel Medical Corporation CMD Stock Holding History

Berman Capital Advisors’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-135
Closed -$9K – 1763
2019
Q4 		$9K Hold
135
– – ﹤0.01% 807
2019
Q3 		$10K Hold
135
– – ﹤0.01% 731
2019
Q2 		$10K Hold
135
– – ﹤0.01% 748
2019
Q1 		$9K Hold
135
– – ﹤0.01% 711
2018
Q4 		$10K Buy
+135
New +$11.1K ﹤0.01% 517

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Berman Capital Advisors's CMD Position: Q1 2020 in Review

Berman Capital Advisors sold out of Cantel Medical Corporation (CMD) in Q1 2020, closing a stake of 135 shares — an estimated $9K sold.

Berman Capital Advisors first reported a position in CMD in Q4 2018 and held it in 5 quarters. The position peaked at $10K in Q3 2019. 213 funds tracked by Wall St. Rank hold CMD as of Q1 2020.

  • Berman Capital Advisors reported no remaining Cantel Medical Corporation position as of Q1 2020 after selling out during the quarter.
  • Berman Capital Advisors sold 135 Cantel Medical Corporation shares in Q1 2020, an estimated $9K.
  • Berman Capital Advisors first reported a position in Cantel Medical Corporation in Q4 2018 and held it in 5 quarters.
  • Berman Capital Advisors's Cantel Medical Corporation position peaked at $10K in Q3 2019.
  • 213 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2020.

Based on Berman Capital Advisors's 13F filing for Q1 2020, filed 14 May 2020.